DCGI
-
Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India
The drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India…
Read More » -
Intas launches DCGI-approved Tofacitinib Ointment to treat atopic dermatitis
Patients who desire a steroid-free topical agent for Atopic Dermatitis will be benefitted Intas Pharmaceuticals, one of India’s leading pharmaceutical…
Read More » -
Akums bags DCGI approval for Perampanel Oral Suspension
The suspension holds the potential to play a key role in improving seizure management, particularly in poorly controlled adults and…
Read More » -
Bharat Biotech’s covid nasal vaccine bags DCGI approval
BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vector vaccine Department of Biotechnology (DBT) and its PSU, Biotechnology Industry Research…
Read More » -
DCGI approves AstraZeneca India’s breast cancer drug
Lynparza is the first and only approved PARPi targeting BRCA-mutated HER2-negative high-risk early breast cancer AstraZeneca India has received Drugs…
Read More » -
PNB Vesper to conduct Phase III clinical trials on covid drug, gets DCGI nod
PNB 001/ GPP-BALACOVIN is proving to be a breakthrough in COVID-19 treatment Kerala-based PNB Vesper has received DCGI permission to…
Read More » -
Sputnik V gets DCGI approval
Dr Reddy’s to import vaccine from Russia Dr Reddy’s has received regulatory approval for the emergency use of Sputnik V,…
Read More » -
COVID-19 vaccines 110 per cent safe: DCGI
DCGI rubbishes impotency rumours As India gears up for the world’s largest vaccination programme, the Drugs Controller General of India…
Read More » -
Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for COVID-19 vaccine
The phase II study of ZyCoV-D had been conducted in over 1,000 healthy adult volunteers as part of the adaptive…
Read More » -
Ready to roll out COVID-19 vaccine in India: Serum
The company has already stockpiled around 50 million dosages of the vaccine Serum Institute of India (SII) on Sunday said…
Read More »